2013 Annual Paris Melanoma Conference.

CALL FOR ABSTRACTS

Participants interested in presenting data should submit abstracts online during the registration process. Abstract submission cannot be done without registering for meeting attendance.

Abstracts are subject to acceptance by the Scientific Committee. Once accepted, abstracts will be published in the final program book and scheduled for oral or poster presentation, as applicable.

Submission Deadline: 26 March 2013

Acceptance notifications and guidelines for poster presentation will be sent on 4 April 2013.  
If your abstract is not accepted you will get a 100% refund of the paid registration fee and hotel accommodation at the Marriott Rive Gauche Hotel booked via prIME Oncology

Abstract Guidelines (Complete Guidelines: click here)

  • Follow instructions provided in complete guidelines (link provided above)
  • Abstracts must be written in English
  • Accepted format: Word document, 9 point Arial font, 500 word count limit
  • List affiliations of author(s) as briefly as possible with city, state (if applicable), and country
  • Place an asterisk (*) before the name of the presenting author
  • Use standard and well-accepted abbreviations
  • When using references, use standard and well-accepted formats
  • Abstract content should be single-spaced, typed in lower case, and contain:
    • Purpose of the study
    • Summarized description of the project
    • Results and conclusions

Meeting Overview

I am pleased to invite you to the 2013 Annual Paris Melanoma Conference, to be held in Paris on 2-3 May 2013.

This conference will provide a highly interactive forum in which leading experts and clinical researchers in the field of melanoma can discuss recent advances in clinical trial data and scientific research. This blend of clinical and scientific research with clinical practice will offer the unique opportunity for participants to be updated on all aspects of melanoma research. Oral presentations and poster sessions will highlight important developments in the field, including emerging therapies and implementation of new treatment strategies. We are certain you will gain valuable insight into the current status of preclinical melanoma research and the application of new trial data into clinical practice to ultimately improve patient care.

I look forward to welcoming you to the 2013 Annual Paris Melanoma Conference.

Sincerely,
Alexander M.M. Eggermont, MD, PhD

Target Audience

This educational activity is specifically designed for medical and surgical oncologists, dermatologists, research scientists, and other healthcare professionals interested in the treatment of patients with melanoma.

Learning Objectives

Upon completion of this educational activity, attendees should be able to:

  • Discuss recent progress in the understanding of melanoma biology, including advances in epidemiology, diagnosis, classification, and biomarkers
  • Examine current data and new strategies for the prevention of melanoma
  • Describe current standards of care and recent advances in the treatment of patients with melanoma, including emerging strategies for adjuvant and neoadjuvant therapy
  • Examine the evolving role of targeted therapies and immunotherapies in the treatment of melanoma
  • Assess new data from melanoma clinical trials and novel clinical trial designs to address unanswered questions in the field

Faculty

Chair
Alexander M. M. Eggermont, MD, PhD
Cancer Institute Gustave Roussy
Villejuif/Paris-Sud, France

 
Confirmed Faculty
Anja Bosserhoff, PhD
University Hospital of Regensburg
Regensburg, Germany

Michele Maio, MD, PhD
University Hospital Siena
Siena, Italy

Dirk Jäger, MD
University Medical Center Heidelberg
Heidelberg, Germany

Jean-Christophe Marine, PhD
Katholieke Universiteit Leuven
Leuven, Belgium

Göran Jönsson, PhD
Lund University
Lund, Sweden

Bart Neyns, MD, PhD
University Hospital Brussels
Brussels, Belgium

Richard Kefford, MBBS, PhD
University of Sydney
Sydney, Australia

Caroline Robert, MD, PhD
Cancer Institute Gustave Roussy
Villejuif/Paris-Sud, France

Ulrich Keilholz, MD
Charité Comprehensive Cancer Center
Berlin, Germany

Dirk Schadendorf, MD, PhD
University Hospital Essen
Essen, Germany

Lionel Larue, PhD
Institute Curie
Paris, France

Lukas Sommer, PhD
University of Zürich
Zürich, Switzerland

Celeste Lebbé, MD, PhD
Hôpital Saint-Louis
Paris, France

Jeffrey S. Weber, MD, PhD
H Lee Moffitt Cancer Center
Tampa, Florida, United States

Paul Lorigan, MB, FRCP
The University of Manchester
Christie NHS Foundation Trust
Manchester, United Kingdom

Laurence Zitvogel, MD, PhD
Cancer Institute Gustave Roussy
Villejuif/Paris-Sud, France

Agenda

Thursday, 2 May
09.00     Opening presentation
Alexander M. M. Eggermont, MD, PhD
SESSION I: New Findings in Melanoma Genesis and Melanoma Stem Cells
9.20     New findings in melanoma genesis
Lionel Larue, PhD

9.45     Stem cells in melanoma
Lukas Sommer, PhD

10.10 – 10.50 Break and poster viewing
SESSION II: Identification of New Drivers and New Targets in Melanoma
10.50     Molecular profiling
Göran Jönsson, PhD

11.15     MIA protein Inhibition
Anja Bosserhoff, PhD

11.40     MdM4 a new target in melanoma
Jean-Christophe Marine, PhD

Luncheon Satellite Symposium (12.30 – 14.00)
SESSION III: Advances in Immunotherapy for Melanoma
14.20     Tumor immunology and new immunomodulators
Dirk Jäger, MD

14.45     The unfolding PD-1/PD-1L story
Caroline Robert, MD, PhD

15.10     Combinations with ipilimumab
Michele Maio, MD, PhD

15.35     Innovations in vaccine development
Bart Neyns, MD, PhD

16.00 – 16.20 Break and poster viewing
SESSION IV: Proffered Papers and Poster Awards (16.20 – 18.30)
Friday, 3 May

SESSION V: Proffered Papers (8.30 – 9.50)
9.50 – 10.10 Break and poster viewing
SESSION VI: Advances in Targeted and Systemic Therapies
10.10     Landscape of driver mutations in melanoma
Dirk Schadendorf, MD, PhD

10.35     Targeted therapies and the immune system
Richard Kefford, MBBS, PhD

11.00     A new mode of action of ipilimumab
Laurence Zitvogel, MD, PhD

11.25     The new era of chemotherapy for melanoma
Paul Lorigan, MB, FRCP

Luncheon Satellite Symposium (12.15 – 13.45)
SESSION VII: New Questions and New Clinical Trial Designs
14.10     Aim at melanoma
Valerie Guild

14.20     Towards targeted therapy in ocular melanoma and monitoring for response
Ulrich Keilholz, MD

14.45     Combination therapies in immunotherapy and targeted agents
Jeffrey S. Weber, MD, PhD

15.10     NRAS inhibitors and targeted trials in mucosal melanoma
Richard Kefford, MBBS, PhD

15.35     Current experience with C-Kit–mutated melanomas
Celeste Lebbé, MD, PhD

16.00     Future combination trials: Are we finding or losing our way?
Alexander M. M. Eggermont, MD, PhD

Registration

FEE FOR ACTIVITY AND REGISTRATION

Physician regular registration: €459,00
Physician full registration: €659,00

Industry regular registration: €449,00
Industry full registration: €559,00

Nurses / Fellows registration: €219,00*
Pharmacists: €329,00*
EORTC Physician Discount: €100,00*

Registration fees include VAT.

*Supporting documentation of eligibility may be required.

Registration includes:

Access to all sessions and exhibition
Lunch and coffee breaks
Congress documentation

Registration Deadlines

Regular registration rate deadline: 19 April 2013


To Register

You may register online before 19 April 2013 at www.prIMEoncology.org/ParisMelanoma2013. Registration confirmations will be issued upon successful registration, and reminders will be issued before the meeting. To preregister, registration information and payment must be received no later than 19 April 2013 (regular registration rate).

Group Registrations

Group registration will be accepted. Further information will be available upon inquiry at
ParisMelanoma2013@prIMEoncology.org

Cancellation

To receive a refund of registration fees, written notice of cancellation must be received at ParisMelanoma2013@prIMEoncology.org

The following deadlines and cancellation fees will apply:

Before 22 February 2013, a €75 administrative charge
Before 26 March 2013: a 80% cancellation fee applies on registration fee(s)
From 26 March 2013: a 100% cancellation fee applies on registration fee(s)


Any registration fees remitted will be refunded after the Conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 26 March 2013.

prIME Oncology does not accept responsibility for reimbursement of travel, accommodation, or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Contact

All inquiries related to the 2013 Annual Paris Melanoma Conference may be addressed to ParisMelanoma2013@prIMEoncology.org



EU OFFICE

Scheveningseweg 58
2517 KW The Hague
the Netherlands

Tel.: + 31 70 3067190
Fax: + 31 70 3318335
Web: www.prIMEoncology.org

HOTEL ACCOMMODATION

A room block has been reserved at the Marriott Rive Gauche, Paris (meeting venue), for delegates of the Melanoma Conference.

Marriott Rive Gauche Hotel
17 Boulevard Saint Jacques
Paris, 75014 France

Check in time: 15.00 hours
Check out time: 12.00 hours


IMPORTANT! Please ensure that you book your hotel accommodation at the Marriott Rive Gauche via the official housing webpage of the Melanoma Conference at:

www.prIMEoncology.org/ParisMelanoma2013

  • If you wish to book accommodations at Marriott Rive Gauche (meeting venue), due to organizational reasons it is mandatory to make your booking via the official Melanoma Conference webpage
  • It is highly recommended that you book your hotel accommodation as early as possible, via the official Melanoma Conference webpage, to avoid rooms being sold out
  • You will benefit from a special competitive rate
  • Please contact us in case of any difficulties with your bookings. In case of any questions or special requirements, please contact us via email: ParisMelanoma2013@prIMEoncology.org or tel: + 31 70 3067190

HOW TO BOOK ACCOMMODATION
  • Book your hotel room online while registering for the congress by clicking on the Registration button at www.prIMEoncology.org/ParisMelanoma2013
    Note: Registering for the conference and booking your hotel room can be done separately. You may login any time to make additional bookings or changes. Payment can be made by credit card.
  • DO NOT book rooms at Marriott Rive Gauche via another (online) source.
  • DO NOT contact Marriott Rive Gauche directly for any questions or bookings related to the congress.
  • For any housing inquiries related to the 2013 Annual Paris Melanoma Conference, please contact us via email:
    ParisMelanoma2013@prIMEoncology.org or tel: + 31 70 3067190

ROOM RATES
Single de Luxe room* € 154- including breakfast and VAT
Double de Luxe room € 164- including breakfast and VAT

* Double room for single occupancy


CANCELLATIONS, CHANGES AND NO-SHOWS
A cancellation fee may apply in the event a delegate cancels his/her (registration and) hotel accommodation. A written notice of cancellation must be received at www.prIMEoncology.org/ParisMelanoma2013.

- From 19 March 2013 a handling fee of €17,50 will be charged for every change.
- From 15 February the cancellation fee will be 80% of the room rate of the entire stay.
- From 25 March 2013 the cancellation fee will be 100% of the room rate of the entire stay.

Any hotel room fees remitted will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be issued in case of no-shows.



BOOKING FLIGHTS

ATP Online is the online booking tool from our preferred travel partner. This online service is offered specifically for all participants of the Melanoma Conference 2013. You can book your flights directly and securely through this online service. The whole process takes only a few steps, saving you time.


To make your reservation, please click here and enter username and password in the “Login” area.  This will take you into an online booking platform that will automatically show all available flights and best available fares.

Login

Username: prime/oncology

Password: prime


Please note that the costs for online bookings are € 17,50 handling cost per flight ticket. Prime Oncology strongly advises you to book your car through your own channel due to limitations and restrictions of these services in ATP Online.

 

ENTRY REQUIREMENTS

Most EU citizens only need their national identity card or passport to enter France. Non-EU citizens require a valid passport to enter France, but many countries are exempt from tourist visas. It is essential that you check with the French embassy or consulate in your country before travelling. Without exception, passports must be valid for at least six months after your planned date of departure from France. 

prIME Oncology will not directly contact embassies and consulates on behalf of applicants. It is the sole responsibility of the delegates to look after their visa requirements.

Note: Passport and visa requirements are liable to change at short notice.  Travelers are advised to check their entry requirements with their embassy or consulate.

INVITATION LETTER

Click here to print your personalized invitation letter for the Conference. The sole purpose of this letter is to facilitate the delegates' travel visa arrangements, and it does not imply the provision of any financial or other support by the organizers.  All expenses incurred in relation to the Conference are the sole responsibility of the delegate.

BOOKING FLIGHTS

ATP Online is the online booking tool from our preferred travel partner. This online service is offered specifically for all participants of the Melanoma Conference 2013. You can book your flights directly and securely through this online service. The whole process takes only a few steps, saving you time.


To make your reservation, please click here and enter username and password in the “Login” area.  This will take you into an online booking platform that will automatically show  all available flights and best available fares.

Login

Username: prime/oncology
Password: prime


Please note that the costs for online bookings are € 17,50 handling cost per flight ticket. Prime Oncology strongly advises you to book your car through your own channel due to limitations and restrictions of these services in ATP Online.

 

GETTING THERE

Public transportation

From train stations

Gare d’ Austerlitz – Metro Line 5 until Place d’Italie, then Metro Line 6 until Glaciere

Gare de l’Est – Metro Line 5 until Place d’Italie, then Metro Line 6 until Glaciere

Gare de Lyon – Metro line 14 until Bercy, then Metro Line 6 until Glaciere

Gare du Nord (Eurostar) – Metro Line 6 until Glaciere

Gare Saint Lazare – Metro line 14 until Bercy, then Metro Line 6 until Glaciere


From airports

Paris Charles de Gaulle Airport (CDG) - RER B until Denfert-Rochereau, then take Metro Line 6 until Glaciere

Paris Orly Airport (ORY) – ORLYBUS until Denfert-Rochereau, then walk to the hotel or take Metro Line 6 until Glaciere

Various passes are available for public transport and can be good value if staying for a longer period. The Paris Visites pass is valid for one, two, three, or five days and also allows discounts at certain museums, shops and restaurants.


Transfer companies

For transfers between Orly or Charles de Gaulle airport to Paris you can use one of the transfer companies:

Parishuttle – book online at Parishuttle or call +33 (0)153 391 818 to reserve your transfer.

VanOparis – book online at VanOparis or call +33 (0) 665 387 888 to reserve your transfer.


Parking on-site
 
The Marriot Rive Hotel allows on-site parking at 25 Euros per day and per car. Early reservations are recommended and subject to availability. Please contact hotel directly!

CLIMATE

Paris has mild and moderately wet weather in the spring.  In May, the average temperatures are between 10o - 15o Celcius (50o - 59o Farenheit) with average rainfall at 45 millimeters (1.78 inches).

TIME ZONE

Paris is in the Central European time zone (GMT +1)

LANGUAGE

French is the official language spoken in Paris, though English is also widely spoken in areas.

CURRENCY

The Euro (EUR) is the official currency in France. Currency can be exchanged at banks, bureaux de change, and some large hotels, though you will get a better exchange rate at the ATMs. Major credit cards are widely accepted, as are travelers cheques, particularly in major tourist destinations. Foreign currency is not accepted.

TAXES

France's value-added tax (VAT) is known as TVA (taxe sur la valeur ajoutée) and is 19.6% on most goods except medicine and books, for which it’s 5.5%. Prices that include TVA are often marked TTC (toutes taxes comprises; literally ‘all taxes included’).

TIPPING

French law requires that restaurant, café, and hotel bills include a service charge (usually between 12% and 15%). Taxi drivers expect small tips of between 5% and 10% of the fare, though the usual procedure is to round up to the nearest €1 regardless of the fare.

SAFETY INFORMATION

Security has been heightened, particularly in the transport sector. Unattended luggage left in public places will be removed or destroyed by security staff. While generally safe, visitors to France are advised to take precautions against petty theft and to ensure their personal safety. Thieves and pickpockets operate on the metro and around airports. Bag snatching is also common, particularly on public transport and in shopping centres, and visitors should also be vigilant of luggage while loading bags into and out of hire cars at airports.

TOURISM WEBSITES

Paris Info

Travelguide

Date And Location

Thursday, 02 May 2013
08.45 - 15.50


Friday, 3 May 2013
08.30 - 16.15

Marriott Rive Gauche Hotel
17 Boulevard Saint Jacques
Paris, 75014
France

Organizer

This is a prIME Oncology activity.

prIME Oncology

Under the auspices of the EORTC

eortc

Endorsing Societies

AIM at Melanoma

save your skin foundation


Continuing Education

2013 Annual Paris Melanoma Conference is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) to provide the following CME activity for medical specialists. The EACCME® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

2013 Annual Paris Melanoma Conference is designated for a maximum of 12 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Support

Support for this educational activity is provided by:

Silver Sponsor

Bristol Myers Squibb logo


Corporate Sponsor

Celgene logo


Contributing Sponsor

Roche


Several options are available to organizations interested in supporting this conference. For more information, please contact Susan Ahn at +1 404 578 9207, or by email at Susan.Ahn@primeoncology.org

Continuing Education

Continue